Wed, Jul 23, 2014, 7:05 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Roche Holding AG Message Board

  • mrcabdrvr1 mrcabdrvr1 Nov 24, 2012 8:44 AM Flag

    Share Price

    Any thoughts on whether the current share price takes into account the acceptance of the Biologics License Application (BLA) for trastuzumab emtansine (T-DM1)? With Roche currently having 3 of the top 10 selling drugs, the approval of T-DM1 in the first half of 2013 will further strengthen their position within Oncology. Biosimiliar activity for Herceptin and Rituxan also appears to be muted at this time.

    Sentiment: Buy

 
RHHBY
36.82-0.01(-0.03%)Jul 23 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.